Enediyne-activated, EGFR-targeted human β-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma
Liu, Wen-juan, Zhu, Kun-li, Xu, Jian, Wang, Jia-lin, Zhu, HuiLanguage:
english
Journal:
Laboratory Investigation
DOI:
10.1038/s41374-018-0109-5
Date:
September, 2018
File:
PDF, 2.35 MB
english, 2018